Cargando…
ID:15949 Evaluating Chronic Use of Opioids in COVID-19 Survivors
Autores principales: | Eshraghi, Yashar, Ali, Haider, Boudreaux, Madison, Alemayehu, Carmel, Burton, Jeffrey, Guirguis, Maged |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163562/ http://dx.doi.org/10.1016/j.neurom.2022.02.153 |
Ejemplares similares
-
Establishing a Dose-Response Relationship Between Opioid Use and Hypogonadism: A Retrospective Case-Control Study
por: Eshraghi, Yashar, et al.
Publicado: (2021) -
Infectious Disease (ID) Learning Unit: What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder
por: Westlake, Amanda A., et al.
Publicado: (2016) -
Chronic Intermittent Hypoxia Is Independently Associated with Reduced Postoperative Opioid Consumption in Bariatric Patients Suffering from Sleep-Disordered Breathing
por: Turan, Alparslan, et al.
Publicado: (2015) -
Evaluation of the COVID19 ID NOW EUA assay
por: Mitchell, Stephanie L., et al.
Publicado: (2020) -
Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)